Cannabis Law Report

JUNE 2, 2021

Aggregate testing results will be reported to the director of the summer camp via safeCircle’s integration with CLEARED4, the Company’s pooled surveillance testing program partner, through CLEARED4’s smartphone-based online health safety management and reporting solution. Testing will be conducted from mid-June through end-July.

Clinical Trials 82

Clinical Trials Therapy Research and Development Collective 82

Cannabis Law Report

DECEMBER 15, 2021

The signing of the MoU follows the joint presentation of initial data by the companies at an American Apparel and Footwear Association event that describes a methodology and findings for the successful determination of Egyptian cotton fiber, yarn and fabric origin using cotton genomics with affirmation by IA.

Supply Chain 52

Supply Chain Therapy Research and Development Events 52

Cannabis Law Report

SEPTEMBER 8, 2021

All the data points associated to tagging and testing are tracked by uploading to a secure cloud database. Leveraging its deep expertise in nucleic acid-based technologies, the Company has also established safeCircle™, a pooled COVID-19 testing program that is grounded in the Company’s EUA-authorized Linea™ COVID-19 Assay Kit.

Supply Chain 96

Supply Chain Therapy Pharmaceutical Food 96

Cannabis Law Report

NOVEMBER 15, 2021

PCR-produced LinearDNA serves as a pure, fast, and flexible alternative to plasmid DNA (pDNA) in the manufacture of cell and gene therapies (CGTs) and nucleic acid vaccines. CRO orders typically provide a means to evaluate LinearDNA within a customer’s preclinical development program. News release. FDA website. January 15, 2019.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

Cannabis Law Report

AUGUST 3, 2021

The Contract specifies ADCL’s deployment of safeCircle™, its high-throughput, pooled COVID-19 testing program, to provide weekly asymptomatic diagnostic COVID-19 screening of on-campus unvaccinated students, staff, and faculty, and a random sampling of vaccinated individuals across the CUNY school system.

Clinical Trials 105

Clinical Trials Therapy Collective Research and Development 105

Cannabis Law Report

JANUARY 18, 2022

ADCL’s safeCircle program is a fully integrated testing platform for enterprise and educational institutions that provides a full range of COVID-19 diagnostic testing and associated services, including sample collection, test site infrastructure design and management, results tracking, and vaccination status management.

Research and Development 52

Research and Development Therapy Supply Chain Collective 52

Cannabis Law Report

NOVEMBER 9, 2021

We find LinearDNA to be an excellent platform for CAR T-cell therapy development.”. These manufacturing complexities have likewise hindered research on CAR T-cell therapies. Dr. James A. About Applied DNA Sciences.

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

Cannabis Law Report

SEPTEMBER 27, 2021

All the data points associated with tagging and testing are tracked by uploading to a secure cloud database. Leveraging its deep expertise in nucleic acid-based technologies, the Company has also established safeCircle™, a pooled COVID-19 testing program that is grounded in the Company’s EUA-authorized Linea™ COVID-19 Assay Kit.

Supply Chain 52

Supply Chain Therapy Research and Development Pharmaceutical 52

Cannabis Law Report

NOVEMBER 9, 2021

Established history of providing FDA-approved ketamine infusion services: The management team at KWC has been in business for 6 years expanding services throughout the United States. Ketamine Wellness Centers (KWC) is the largest ketamine therapy provider in the United States with 10 clinic locations serving communities across eight states.

Treatment 52

Treatment Therapy Media Access 52

Cannabis Law Report

DECEMBER 21, 2021

This calendar year marks a synchronous period in Dalrada’s history when its impactful innovations and solutions of all its subsidiaries expanded market presence into the top three largest growing industries : clean energy, healthcare, and technology. Prakat swiftly modernizes legacy business hardware, software programs, and downloadable apps.

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

JULY 30, 2019

In my estimation, the state’s overall program growth in Florida to date is impressive. The ASA highlights that it takes the FDA “an average of 9 years to approve any drug, but it only takes approximately two to four weeks for a medical cannabis patient with chronic pain to be approved by a state program.”

Marijuana 40

Marijuana Education Patients Research and Development 40

The Cannigma

AUGUST 5, 2022

2 In 2019 the FDA approved a keta m ine-based nasal spray to treat depression that does not respond to other therapies. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” But this program offers more than just the ketamine itself.

Treatment 138

Treatment Research and Development Therapy Digestion 138

Cannabis Law Report

JANUARY 4, 2022

Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. Hurry, 917-733-5573, sanjay.hurry@adnas.com safeCircle Program Manager: Mike Munzer, 631-240-8814, mike.munzer@adnas.com Web: www.adnas.com Twitter: @APDN. Assay (the “Linea 2.0 The Linea 2.0

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

JANUARY 21, 2022

ADCL’s safeCircle program is a fully integrated testing platform for enterprise and educational institutions that provides a full range of COVID-19 diagnostic testing and associated services, including sample collection, test site infrastructure design and management, results tracking, and vaccination status management.

Collective 52

Collective Therapy Research and Development Supply Chain 52

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. In MAPS’ 36th year, we’ll learn if our second Phase 3 study of MDMA-assisted therapy for PTSD was successful. At 36, MAPS is now older than I was when I started MAPS at age 32.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

NOVEMBER 5, 2021

Vaccinated participants in the safeCircle program are given a ‘blue pass.’ CLEARED4 captures, validates and matches user’s information to real-time health data including health surveys, temperature screening, integrated COVID-19 test results and vaccination status. For Applied DNA: Investor Contact: Sanjay M.

Compliance 52

Compliance Compliance Research and Development Therapy 52

Cannabis Law Report

JANUARY 28, 2022

Hurry, 917-733-5573, sanjay.hurry@adnas.com safeCircle Program Manager: Mike Munzer, 631-240-8814, mike.munzer@adnas.com Web: www.adnas.com Twitter: @APDN. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Investor Relations Contact: Sanjay M.

Therapy 52

Therapy Research and Development Supply Chain Events 52

The Cannigma

APRIL 8, 2021

We’ve actually had one or maybe even two cannabis pharmacists on this program before. It’s not a targeted therapy, that’s why it’s so good at symptom relief, but it hasn’t fix much of anything. They’re not taking good med histories. We don’t have any data if someone is using a Type III-high CBD strain in pregnancy.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

OCTOBER 25, 2021

Hurry, 917-733-5573, sanjay.hurry@adnas.com Program Manager: Dr. James Hayward, 631-240-8801, james.hayward@adnas.com Web: www.adnas.com Twitter: @APDN. Applied DNA has also established a COVID-19 diagnostic and testing offering that is grounded in the Company’s deep expertise in DNA. For Applied DNA: Investor: Sanjay M.

Research and Development 52

Research and Development Therapy Collective Treatment 52

Cannabis Law Report

JUNE 4, 2021

He is the creator and director of the television series Hamilton’s Pharmacopeia, in which he investigates the chemistry, history, and cultural impact of various psychoactive drugs. Brian Muraresku is the New York Times Bestselling author of The Immortality Key: The Secret History of the Religion with No Name. Brian Muraresku.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JULY 30, 2019

The informed patients, cannabis industry employees, and clinicians find it equally difficult to keep updated on Florida’s latest medical marijuana program news and changes. . A confusing amalgam of individual state programs and a pattern of national litigation and reversals litters the U.S. In our current U.S. landscape. .

Marijuana 45

Marijuana Patients Research and Development Programs 45